Alerts will be sent to your verified email
Verify Email
AJANTPHARM
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Ajanta Pharma Limited is a specialty pharmaceuticals formulation company with a diverse Branded Generics business in India, Asia, and Africa. They focus on chronic diseases, innovation, and have verticals in US Generics and Institutional business in Africa.
Ajanta Pharma major competitors are Gland Pharma, JB Chem & Pharma, Ipca Laboratories, Eris Lifesciences, Pfizer, Wockhardt, Astrazeneca Pharma I.
Market Cap of Ajanta Pharma is ₹30,635 Crs.
While the median market cap of its peers are ₹24,226 Crs.
Ajanta Pharma seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Apr Jul | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Jun Sep Dec | ||||||
| Investor Presentation | Apr Jul | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Jun Sep Dec | ||||||
| Conference Call | Mar Jun | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | |||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
